投资策划网—规模最大、实力最强的研究报告提供商! 关于我们 联系中撰 网站地图
稳评报告
当前位置:主页 > 稳评报告 > >> China Blood Products Industry Report, 2012-2016
China Blood Products Industry Report, 2012-2016
2012-06-19 09:31共有人浏览
更多
内 容
 

 

【Table of Contents】 

1. Profile of Blood Products
1.1 Definition
1.2 Classification
1.3 Recombinant Blood Products
1.4 Industry Chain
1.5 Features

2. Overview of China Blood Products Industry
2.1 Market Size
2.2 Development Status
2.3 Market Supply & Demand
2.3.1 Supply 
2.3.2 Demand 
2.4 Market Competition
2.5 Operating Environment
2.5.1 International Market
2.5.2 Policies
2.5.3 Domestic Biopharmaceutical Market
2.6 Import & Export

3. Blood Product Market Segments in China
3.1 Human Albumin
3.1.1 Supply & Demand
3.1.2 Competition Pattern
3.1.3 Prospects
3.2 Human Immunoglobulin (pH4) for Intravenous Injection
   3.2.1Supply & Demand
3.2.2 Competition Pattern
3.3 Coagulation Factor
3.3.1 Supply & Demand
3.3.2 Competition Pattern
3.3.3 Prospects
3.4 Hepatitis B Immunoglobulin
3.4.1 Supply & Demand
3.4.2 Competition Pattern
3.5 Human Immunoglobulin
3.5.1 Supply & Demand
3.5.2 Competition Pattern
3.6 Human Prothrombin Complex
3.6.1 Supply & Demand
3.6.2 Competition Pattern
3.7 Tetanus Immunoglobulin
3.7.1 Supply & Demand
3.7.2 Competition Pattern
3.8 Rabies Immunoglobulin
3.8.1 Supply & Demand
3.8.2 Competition Pattern

4. Key Manufacturers in China
4.1 Hualan Biological Engineering Inc.
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 Clients and Suppliers
4.1.6 R&D and Investment
4.1.7 Blood Products
4.2 Shanghai RAAS Blood Products Co., Ltd.
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 Clients and Suppliers
4.2.6 R&D and Investment
4.3 Beijing Tiantan Biological Products Co., Ltd.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 Clients and Suppliers
4.3.6 Blood Products
4.4 China Biologic Products Inc.
4.4.1 Profile
4.4.2 Operation
4.4.4 Cost Analysis
4.4.5 Clients and Suppliers
4.4.6 Shandong Taibang Biological Products Co., Ltd.
4.4.7 Guiyang Qianfeng Biological Products Co., Ltd.
4.4.8 Xi’an Hui Tian Blood Products Co., Ltd.
4.5 Jiangxi Boya Biopharmaceutical Co., Ltd.
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 Clients and Suppliers
4.5.6 Output & Sales Volume and Price
4.5.7 R&D and Investment
4.6 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
4.6.1 Profile
4.6.2 Blood Products
4.7 CNBG Shanghai Institute of Biological Products
4.7.1 Profile
4.7.2 Blood Products
4.8 Shanxi Kangbao Biological Product Co., Ltd.
4.8.1 Profile
4.8.2 Blood Products
4.9 Green Cross
4.9.1 Profile
4.9.2 Blood Products


【Figures & Tables】

Basic Components of Blood
Classification and Effects of Blood Products
Comparison between Gene Recombinant Blood Products and Traditional Blood Products
Categories and Comparison of Recombinant Blood Products in China and Worldwide
Blood Product Industry Chain
Blood Product Market Scale in China, 2003-2015E
Lot Release Volume of Blood Products (by Product) in China, 2007-2011
Product Structure of Blood Products in China (by Lot Release Volume), 2009-2011 
Annual Plasma Volume in China, 2002-2011 
Geographical Distribution of Plasma Collection Station Resources in China, by the End of 2011
Medical Insurance Coverage in Mainstream Blood Products in China
Comparison of Per Capita Usage of Blood Products between China and Developed Countries
Distribution of Plasma Collection Stations, Plasma Volume and Blood Products Revenue of Chinese Major Blood Product Manufacturers, 2011
Comparison among Blood Product Manufacturing Enterprises in China by Product Line
Blood Products in Overseas Countries
On-going Clinical Trial of New Indications Overseas
Global Blood Products Manufacturers
Major Policies Concerning Blood Products in China
Sales Value and Total Profit of Biological & Biochemical Product Industry in China, 2008-2011
Ratio of Domestic and Imported Human Albumin in China (by Lot Release Volume), 2007-2010
Market Share of Major Manufacturers of Human Albumin in China (by Lot Release Volume), 2007-2011
Comparison between China and USA by Consumption of Human Immunoglobulin (pH4) for Intravenous Injection, 2010
Lot Release Volume and Its Growth Rate of Human Immunoglobulin (pH4) for Intravenous Injection in China, 2007-2010 
Prices of Human Immunoglobulin (pH4) for Intravenous Injection in China and Other Countries
Market Share of Major Manufacturers of Human Immunoglobulin (pH4) for Intravenous Injection in China (by Lot Release Volume), 2007-2011
Lot Release Volume and Its Growth Rate of Coagulation Factor VIII in China, 2008-2011 
Market Share of Major Manufacturers of Coagulation Factor VIII in China (by Lot Release Volume), 2008-2011
Comparison between Human-derived Coagulation Factor VIII and Recombinant Coagulation Factor VIII
Lot Release Volume and Its Growth Rate of Hepatitis B Immunoglobulin in China, 2008-2011 
Market Share of Major Manufacturers of Hepatitis B Immunoglobulin in China (by Lot Release Volume), 2008-2011
Lot Release Volume and Its Growth Rate of Human Immunoglobulin in China, 2008-2011 
Market Share of Major Manufacturers of Human Immunoglobulin in China (by Lot Release Volume), 2008-2011
Lot Release Volume and Its Growth Rate of Human Prothrombin Complex in China, 2008-2011
Market Share of Manufacturers of Human Prothrombin Complex in China (by Release Volume), 2008-2011
Lot Release Volume and Its Growth Rate of Tetanus Immunoglobulin in China, 2008-2011 
Market Share of Major Manufacturers of Tetanus Immunoglobulin in China (by Release Volume), 2008-2011
Lot Release Volume and Its Growth Rate of Human Rabies Immunoglobulin in China, 2008-2011
Market Share of Major Manufacturers of Human Rabies Immunoglobulin in China (by Release Volume), 2008-2011
Revenue and Total Profit of Hualan Biological, 2007-2012
Revenue Breakdown of Hualan Biological by Industry, 2007-2011 
Revenue Structure of Hualan Biological by Industry, 2007-2011
Revenue Breakdown of Hualan Biological by Product, 2007-2011 
Revenue Structure of Hualan Biological by Product, 2007-2011
Revenue Breakdown of Hualan Biological by Region, 2007-2011 
Revenue Structure of Hualan Biological by Region, 2007-2011
Gross Margin of Hualan Biological by Industry, 2007-2011
Gross Margin of Hualan Biological by Product, 2007-2011
Hualan Biological’s Revenue from Top 5 Clients and % of Total Revenue, 2007-2011
Hualan Biological’s Procurement from Top 5 Suppliers and % of Total Procurement,2007-2011
R&D Costs and % of Total Revenue of Hualan Biological, 2007-2011
Distribution of Plasma Collection Stations of Hualan Biological, 2011
Lot Release Volume of Blood Products of Hualan Biological, 2008-2011 
Proportion of Blood Products Release Volume of Hualan Biological, 2008-2011
Revenue and Gross Margin of Blood Products of Hualan Biological, 2007-2011 
Revenue and Gross Margin of Blood Products of Hualan Biological (by Product), 2007-2011
Distribution of Plasma Collection Stations of Shanghai RAAS Blood Products Co., Ltd, by the End of 2011
Revenue and Profit of Shanghai RAAS, 2007-2012
Lot Release Volume of Blood Products of Shanghai RAAS Blood Products Co., Ltd, 2007-2011
Proportion of Blood Products Release Volume of Shanghai RAAS, 2007-2011
Revenue Breakdown of Shanghai RAAS by Product, 2007-2011 
Revenue Structure of Shanghai RAAS by Product, 2007-2011
Revenue Breakdown of Shanghai RAAS by Region, 2007-2011
Revenue Structure of Shanghai RAAS by Region, 2007-2011
Gross Margin of Shanghai RAAS by Product, 2007-2011
Shanghai RAAS’s Revenue from Top 5 Clients and % of Total Revenue,2007-2011
Name List and Revenue Contribution of Shanghai RAAS’s Top 5 Clients, 2011
Shanghai RAAS’s Procurement from Top 5 Suppliers and % of Total Procurement,2007-2011
R&D Costs and % of Total Revenue of Shanghai RAAS,2007-2011
Revenue and Net Income of Tiantan Biological’s Major Joint-stock Companies, 2011
Revenue and Total Profit of Beijing Tiantan Biological, 2007-2012
Revenue Breakdown of Beijing Tiantan Biological by Industry, 2007-2011
Revenue Breakdown of Beijing Tiantan Biological by Region, 2007-2011
Gross Margin of Beijing Tiantan Biological by Industry, 2007-2011
Beijing Tiantan Biological’s Procurement from Top 5 Suppliers and % of Total Procurement, 
2007-2011
Beijing Tiantan Biological’s Revenue from Top 5 Clients and % of Total Revenue, 2007-2011
Name List and Revenue Contribution of Top 5 Clients of Beijing Tiantan Biological’s Top 5 Clients, 2011
Distribution of Plasma Collection Stations of Beijing Tiantan Biological, by the End of 2011
Revenue and Gross Margin of Blood Products of Beijing Tiantan Biological, 2007-2011
Lot Release Volume of Blood Products of Chengdu Rongsheng, 2007-2011
Equity Structure of China Biologic Product Inc.
Revenue and Operating Income of China Biologic Products Inc., 2007-2011
Revenue Structure of China Biologic Products Inc. by Product, 2008-2011
Plasma Collection Costs of China Biologic Products Inc., 2008-2011
China Biologic Products Inc.’s Revenue from Top 5 Clients and % of Total Revenue, 2008-2011
Name List and Revenue Contribution of China Biologic Products Inc.’s Top 5 Clients, 2011
Name List and Procurement Contribution of China Biologic Products Inc.’s Top 10 Suppliers, 2011
Lot Release Volume of Blood Products of Shandong Taibang, 2007-2011
Lot Release Volume of Blood Products of Guiyang Qianfeng, 2007-2011 
Lot Release Volume of Blood Products of Xi’an Hui Tian, 2007-2011
Plasma Inventory, Plasma Collection Amount and Plasma Volume of Boya Biopharmaceutical, 2009-2011
Distribution and Collection Amount of Plasma Collection Stations of Boya Biopharmaceutical, 2009-2011
Revenue and Profit of Boya Biopharmaceutical, 2009-2012
Revenue Breakdown of Boya Biopharmaceutical by Product, 2009-2011
Revenue Structure of Boya Biopharmaceutical by Product, 2009-2011
Lot Release Volume of Blood Products of Boya Biopharmaceutical, 2007-2011
Revenue Breakdown of Boya Biopharmaceutical by Region, 2009-2011
Revenue Structure of Boya Biopharmaceutical by Region, 2009-2011
Gross Margin of Boya Biopharmaceutical by Product, 2009-2011
Boya Biopharmaceutical’s Revenue from Top 5 Clients and % of Total Revenue, 2009-2011 
Name List and Revenue Contribution of Boya Biopharmaceutical’s Top 5 Clients, 2011
Boya Biopharmaceutical’s Procurement from Top 5 Suppliers and % of Total Procurement,2009-2011 
Name List and Procurement Contribution of Boya Biopharmaceutical’s Top 5 Suppliers, 2011
Output & Sales Volume and Inventory of Boya Biopharmaceutical by Product, 2009-2011 
Prices of Boya Biopharmaceutical by Product, 2009-2011
R&D Costs and % of Total Revenue of Boya Biopharmaceutical, 2009-2011
Blood Product R&D Projects and Progress of Boya Biopharmaceutical, by the End of 2011
Distribution of Plasma Collection Stations of Yuanda Shuyang, by the End of 2011
Lot Release Volume of Blood Products of Yuanda Shuyang, 2007-2011
Lot Release Volume of Blood Products of CNBG Shanghai Institute of Biological Products, 2007-2011
Distribution of Plasma Collection Stations of CNBG Shanghai Institute of Biological Products, by the End of 2011
Distribution of Plasma Collection Stations of Shanxi Kangbao, by the End of 2011
Lot Release Volume of Blood Products of Shanxi Kangbao, 2007-2011 
Distribution of Plasma Collection Stations of Green Cross, by the End of 2011
Lot Release Volume of Blood Products of Green Cross, 2007-2011 


【编辑:中国投资政策网】 TOP
专项定制报告专项定制报告分类
专项报告类别:
商业计划书 | 可行性研究报告 | 资金申请报告
可行性报告 | 项目申请报告 | 英文报告
联系方式
·联系人:
余先生、方小姐
·电话号码:
15989039303、(0086)020-66699282
·地址:
广州市番禺区桥南街福德路241号奥园广场塔三1305室

订购流程订购流程
① 签订可行性报告订购合同;
② 通过银行转帐、邮局汇款等形式款项;
③ 中国投资策划网见到汇款底单或者转帐底单后,24小时内发送可行性研究报告电子版,72小时内寄送正式版以及发票。